It’s no secret that the Patient Protection and Affordable Care Act has affected the insurance industry from top to bottom. In order to survive and thrive, operators have had to adhere to part of the mantra of the U.S. Marines: adapt and overcome.

One such company, U.S. Advisors Inc. of Brentwood, Tennessee, in August started offering an assurance program to hospitals and surgeons who use a prescription drug called Cellerate, which is used to treat surgical incisions and major lacerations. Cellerate works to speed the healing process so patients who have undergone major surgery recuperate from their incisions faster. It also has been used to prevent amputations performed on diabetics, and as a barrier to prevent further infections.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Dig Deeper



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.